Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults

View ORCID ProfileDenis Nash, Madhura S. Rane, Mindy Chang, Sarah Gorrell Kulkarni, View ORCID ProfileRebecca Zimba, View ORCID ProfileWilliam You, Amanda Berry, Chloe Mirzayi, Shivani Kochhar, Andrew Maroko, View ORCID ProfileMcKaylee M. Robertson, View ORCID ProfileDrew A. Westmoreland, Angela M. Parcesepe, View ORCID ProfileLevi Waldron, Christian Grov
doi: https://doi.org/10.1101/2021.02.12.21251659
Denis Nash
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Denis Nash
  • For correspondence: denis.nash@sph.cuny.edu
Madhura S. Rane
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mindy Chang
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Gorrell Kulkarni
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Zimba
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca Zimba
William You
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William You
Amanda Berry
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chloe Mirzayi
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shivani Kochhar
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Maroko
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
3Department of Environmental, Occupational, and Geospatial Health Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
McKaylee M. Robertson
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for McKaylee M. Robertson
Drew A. Westmoreland
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Drew A. Westmoreland
Angela M. Parcesepe
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
4Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, USA
5Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Levi Waldron
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Levi Waldron
Christian Grov
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York City, New York USA
6Department of Community Health and Social Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York City, New York USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Epidemiologic risk factors for incident SARS-CoV-2 infection as determined via prospective cohort studies greatly augment and complement information from case-based surveillance and cross-sectional seroprevalence surveys.

Methods We estimated the incidence of SARS-CoV-2 infection and risk factors in a well-characterized, national prospective cohort of 6,738 U.S. adults, enrolled March-August 2020, a subset of whom (n=4,510) underwent repeat serologic testing between May 2020 and January 2021. We examined the crude associations of sociodemographic factors, epidemiologic risk factors, and county-level community transmission with the incidence of seroconversion. In multivariable Poisson models we examined the association of social distancing and a composite score of several epidemiologic risk factors with the rate of seroconversion.

Findings Among the 4,510 individuals with at least one serologic test, 323 (7.3%, 95% confidence interval [CI] 6.5%-8.1%) seroconverted by January 2021. Among 3,422 participants seronegative in May-September 2020 and tested during November 2020-January 2021, we observed 161 seroconversions over 1,646 person-years of follow-up (incidence rate of 9.8 per 100 person-years [95%CI 8.3-11.5]). In adjusted models, participants who reported always or sometimes social distancing with people they knew (IRRalways vs. never 0.43, 95%CI 0.21-1.0; IRRsometimes vs. never 0.47, 95%CI 0.22-1.2) and people they did not know (IRRalways vs. never 0.64, 95%CI 0.39-1.1; IRRsometimes vs. never 0.60, 95%CI 0.38-0.97) had lower rates of seroconversion. The rate of seroconversion increased across tertiles of the composite score of epidemiologic risk (IRRmedium vs. low 1.5, 95%CI 0.92-2.4; IRRhigh vs. low 3.0, 95%CI 2.0-4.6). Among the 161 observed seroconversions, 28% reported no symptoms of COVID-like illness (i.e., were asymptomatic), and 27% reported a positive SARS-CoV-2 diagnostic test. Ultimately, only 29% reported isolating and 19% were asked about contacts.

Interpretation Modifiable epidemiologic risk factors and poor reach of public health strategies drove SARS-CoV-2 transmission across the U.S during May 2020-January 2021.

Funding U.S. National Institutes of Allergy and Infectious Diseases (NIAID).

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Not an intervention study

Clinical Protocols

https://bmjopen.bmj.com/content/11/9/e048778

Funding Statement

Funding for this project is provided by The National Institute of Allergy and Infectious Diseases (NIAID), award number 3UH3AI133675-04S1 (MPIs: D Nash and C Grov), the CUNY Institute for Implementation Science in Population Health (cunyisph.org) and the COVID-19 Grant Program of the CUNY Graduate School of Public Health and Health Policy, and National Institute of Child Health and Human Development grant P2C HD050924 (Carolina Population Center).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the Institutional Review Board at the City University of New York (CUNY) Graduate School for Public Health and Health Policy.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • CONFLICTS OF INTEREST: None declared

Data Availability

The data that support the findings of this study are available on request from the corresponding author, [DN]. The data are not yet publicly available, but we are preparing to post a deidentified, HIPAA compliant, public use version of our baseline and follow-up data on GitHub.

https://cunyisph.org/chasing-covid/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 12, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults
Denis Nash, Madhura S. Rane, Mindy Chang, Sarah Gorrell Kulkarni, Rebecca Zimba, William You, Amanda Berry, Chloe Mirzayi, Shivani Kochhar, Andrew Maroko, McKaylee M. Robertson, Drew A. Westmoreland, Angela M. Parcesepe, Levi Waldron, Christian Grov
medRxiv 2021.02.12.21251659; doi: https://doi.org/10.1101/2021.02.12.21251659
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults
Denis Nash, Madhura S. Rane, Mindy Chang, Sarah Gorrell Kulkarni, Rebecca Zimba, William You, Amanda Berry, Chloe Mirzayi, Shivani Kochhar, Andrew Maroko, McKaylee M. Robertson, Drew A. Westmoreland, Angela M. Parcesepe, Levi Waldron, Christian Grov
medRxiv 2021.02.12.21251659; doi: https://doi.org/10.1101/2021.02.12.21251659

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1947)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (699)
  • Epidemiology (11102)
  • Forensic Medicine (8)
  • Gastroenterology (624)
  • Genetic and Genomic Medicine (3168)
  • Geriatric Medicine (309)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12720)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2986)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1552)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2785)
  • Public and Global Health (5591)
  • Radiology and Imaging (1094)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (760)
  • Rheumatology (339)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)